Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
CX-516 is an ampakine and nootropic that acts as an AMPA receptor positive allosteric modulator and had been undergoing development by a collaboration between Cortex, Shire, and Servier. It was studied as a potential treatment for Alzheimer's disease under the brand name Ampalex, and was also being examined as a treatment for ADHD.
Overview, Related Topics & Entities
Explore the main themes, entities and connections around CX-516. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
ampakine cortex positive compound animal also name ampalex half-life ampa receptor allosteric modulator drugs mw-parser-output font-weight nootropic development shire servier
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| CX-516 | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| CX-516 | CAS Number | 154235-83-3 Y | 1.00 | infobox |
| CX-516 | ChEMBL | ChEMBL136800 Y | 1.00 | infobox |
| CX-516 | ChemSpider | 130635 Y | 1.00 | infobox |
| CX-516 | CompTox Dashboard (EPA) | DTXSID70165574 | 1.00 | infobox |
| CX-516 | ECHA InfoCard | 100.237.047 | 1.00 | infobox |
| CX-516 | Elimination half-life | 45 minutes | 1.00 | infobox |
| CX-516 | Formula | C14H15N3O | 1.00 | infobox |
| CX-516 | IUPHAR/BPS | 4165 | 1.00 | infobox |
| CX-516 | KEGG | C13675 Y | 1.00 | infobox |
| CX-516 | Molar mass | 241.294 g·mol−1 | 1.00 | infobox |
| CX-516 | PubChem CID | 148184 | 1.00 | infobox |
| CX-516 | Trade names | Ampalex | 1.00 | infobox |
| CX-516 | UNII | Z5QU38B4V9 | 1.00 | infobox |
| CX-516 | is a | ampakine and nootropic that acts as an AMPA receptor positive allosteric modulator and had been undergoing development by a collaboration between Cortex | 0.90 | text |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.